1. Home
  2. EARN vs STXS Comparison

EARN vs STXS Comparison

Compare EARN & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

N/A

Current Price

$4.34

Market Cap

169.8M

Sector

Real Estate

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$1.30

Market Cap

139.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EARN
STXS
Founded
2012
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.8M
139.3M
IPO Year
2012
2004

Fundamental Metrics

Financial Performance
Metric
EARN
STXS
Price
$4.34
$1.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$5.38
$4.00
AVG Volume (30 Days)
360.4K
538.4K
Earning Date
06-16-2026
05-12-2026
Dividend Yield
20.51%
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
$7.69
$28.22
Revenue Next Year
$19.57
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$1.24
52 Week High
$5.77
$3.59

Technical Indicators

Market Signals
Indicator
EARN
STXS
Relative Strength Index (RSI) 45.40 37.21
Support Level $4.29 $1.30
Resistance Level $4.49 $1.51
Average True Range (ATR) 0.07 0.06
MACD -0.01 -0.00
Stochastic Oscillator 22.50 0.00

Price Performance

Historical Comparison
EARN
STXS

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co The Fund is focused on acquiring and actively managing a portfolio of corporate CLOs, mainly mezzanine debt and equity tranches, which are typically collateralized by portfolios consisting mainly of below-investment-grade senior secured loans with a large number of discrete underlying borrowers across various industry sectors. Additionally, the Fund may also invest in CLO loan accumulation facilities, which are entities that acquire corporate loans and other similar corporate credit-related assets in anticipation of ultimately collateralizing a CLO transaction. The company's primary investment objectives are to generate attractive current income and risk-adjusted total returns for shareholders.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: